Roles of Uremic Toxins in Uremic Sacropenia
Launched by TUNGS' TAICHUNG METROHARBOUR HOSPITAL · Feb 17, 2017
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Patients and Methods
This study will included 300 consecutive patients receiving maintenance hemodialysis at the outpatient dialysis center of the Tungs Taichung Metroharbour Hospital, Taichung Taiwan. Recruitment will start after approval of the Ethics Committee of our hospital. Exclusion criteria were age of \<20 and \>90 years, clinical signs of acute infection during the month preceding the inclusion, active cancer or liver disease at the time of evaluation, previous diagnosis of immunological diseases and unwillingness to participate in the study. Physician will perform a complete cha...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both sexes aged between 20-90 years. Received stable hemodialysis at least 3 months. Written informed consent.
- Exclusion Criteria:
- • clinical signs of acute infection during the month preceding the inclusion, active cancer or liver disease at the time of evaluation, previous diagnosis of immunological diseases and unwillingness to participate in the study.
About Tungs' Taichung Metroharbour Hospital
Tungs' Taichung Metroharbour Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and improving patient outcomes through innovative clinical trials. With state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals, the hospital focuses on a wide range of therapeutic areas, emphasizing patient safety and ethical standards. By fostering collaborations with academic institutions and industry partners, Tungs' Taichung Metroharbour Hospital aims to contribute significantly to the global body of medical knowledge while ensuring the highest standards of care for its patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Trial Officials
Paik Seong Lim, PhD
Principal Investigator
Tungs' Taichung Metroharbour Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials